Toxicity, recurrence and survival after adjuvant radiotherapy treatment for FIGO stage I cancer of the endometrium

Clinical Oncology

Volumn 15, Issue 5, 2003, Pages 250-254

  Moss, E L ^a   Stevens, A ^a   Gray, L ^b   McConkey, C ^b   Fernando, I ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Adjuvant radiotherapy; Endometrial cancer; Recurrence; Survival; Toxicity; Vaginal vault brachytherapy

Indexed keywords

ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HOSPITAL DEPARTMENT; HUMAN; MAJOR CLINICAL STUDY; NONBIOLOGICAL MODEL; PATIENT REFERRAL; PRIORITY JOURNAL; RADIATION INJURY; RECURRENCE RISK; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED KINGDOM; UNIVERSITY HOSPITAL; VAGINA DISEASE;

EID: 0043132215     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(03)00149-3     Document Type: Article

References (14)

1. Nori D, Merimsky O, Batata M, et al. Postoperative high dose-rate intravaginal brachytherapy combined with external irradiation for early stage endometrial cancer: a long-term follow-up. Int J Radiat Oncol Biol Phys 1994;30:831-837.
2. Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC study group. Post-operative radiation therapy in endometrial carcinoma. Lancet 2000;355:1404-1411.
3. Weiss E, Hirnle E, Arnold-Bofinger A, et al. Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma: patterns of relapse and side effects following low-dose therapy. Gynecol Oncol 1998;71:72-76.
4. Chadha M, Nanavati PJ, Liu P, et al. Patterns of failure in endometrial carcinoma stage 1B grade 3 and 1C patients treated with postoperative vaginal vault brachytherapy. Gynecol Oncol 1999;75:103-107.
5. MacLeod C, Fowler A, Duval P, et al. High-dose-rate brachytherapy alone post-hysterectomy for endometrial cancer. Int J Radiat Oncol Biol Phys 1998;42:1033-1039.
6. Burger M. Management of stage 1 endometrial carcinoma. Postoperative radiotherapy is not justified in women with medium risk disease. BMJ 2001;322:568-569.
7. Thomas R, Blake P. Endometrial carcinoma: adjuvant loco-regional therapy. Clin Oncol 1996;8:140-145.
8. Yalman D, Ozsaran Z, Anacak Y, et al. Postoperative radiotherapy in endometrial carcinoma: analysis of prognostic factors in 440 cases. Eur J Gynaecol Oncol 2000;21:311-315.
9. Rubin P, Constine L, Fajardo LF, et al. RTOG Late effects working group. Overview. Late effects of normal tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 1995;31:1041-1042.
10. Weigensberg IJ. Preoperative radiotherapy in endometrial carcinoma: preliminary report of a clinical trial. Am J Roentegenol 1976; 127:319-323.
11. Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgico-pathological risk factors and outcome in Stage I and II carcinoma of the endometrium: A gynaecological Oncology Group Study. Gynecol Oncol 1990;40:55-65.
12. Bliss P, Cowie VJ. Endometrial carcinoma: does the addition of intracavitary vault caesium for external beam therapy postoperatively result in improved control or increased morbidity? Clin Oncol 1992;4:373-376.
13. Aalders J, Abeler V, Kolstad P, et al. Postoperative external irradiation and prognostic parameters in Stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynaecol 1980;56:419-427.
14. Irwin C, Levin W, Fyles A, et al. The role of adjuvant radiotherapy in carcinoma of the endometrium-results in 550 patients with pathologic stage I disease. Gynecol Oncol 1998;70:247-254.